Case Study

Maximizing Drug Formulation for First-In-Human Trials

Format: PDF file | Document type: Case Study | Promoted Content

This content is provided by Altasciences, and any views and opinions expressed do not necessarily reflect those of

Maximizing Drug Formulation for First-In-Human Trials

The manufacture of a drug product for clinical trials is of critical importance. The formulation, manufacturing, and assessment of a drug candidate during first-in-human (FIH) trials can be contributing factors in whether the drug safely provides the correct dosage and gains regulatory approval. An integrated approach, which combines formulation development, GMP manufacturing, release testing, and clinical testing, has been proven to shorten timelines, reduce costs, and improve flexibility.

Discover how we can accelerate your drug’s development and get it to market, fast. Case study included.

Related resources from Altasciences

Show more

Supplier info centre